![Rauno Hoffmann, Global Head of Corporate Compliance Management System, Novartis [SWX: NOVN] | Pharma Tech Outlook Europe](https://www.pharmatechoutlookeurope.com/newstransfer/upload/450x308_98n4.jpg "Rauno Hoffmann, Global Head of Corporate Compliance Management System, Novartis [SWX: NOVN] | Pharma Tech Outlook Europe")
![Liselotte Hyveled, Board member, Novo Nordisk [CPH: NOVO-B] | Pharma Tech Outlook Europe](https://www.pharmatechoutlookeurope.com/newstransfer/upload/Untitled-11_450x308_gf6W.jpg "Liselotte Hyveled, Board member, Novo Nordisk [CPH: NOVO-B] | Pharma Tech Outlook Europe")
Shaping the Next Chapter of Manufacturing
Chow Woai Sheng, Vice President of Global Instrument Manufacturing and Singapore General Manager, Agilent Technologies
Unlocking Efficiency by Implementing AI in Pharma Manufacturing
Veronique Kodjo, EVP Global Manufacturing, Supply Chain & Quality, Ceva Santé Animale
Mitigating Manufacturers’ Exposure to US MFN Policy Through European Repricing
Leandro Domingues, Senior Engagement Manager, and Audrey Lee, Consultant, Syneos Health Commercial Solutions
Leveraging AI/ML to Transform Pharmaceutical Industry
Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals
Overcoming The Medical Industry's Supply Chain Challenges
Erik Lemay, Global Head of External Manufacturing, Servier
How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development
Stewart Campbell, VP & General Manager, West Pharmaceutical Services, Inc.
Risk-Based Approach in Vendor Assessment for Clinical Trials (CT) Services
Inguna AdovičaHead of Clinical Research Quality Division, Head of Medicine and Clinical Research DepartmentVadims Ķīsis, JSC Olainfarm
From Pharmaceutical Parallel Importer to Building Brands
Line Bentsen ZachoMarketing DirectorOrifarm
Regulatory Strategy, The Maestro
Ines Silva, Regulatory Strategy Director, ICON Strategic Solutions
Early R&D Decisions Shaping Generic Drug Regulatory Success
Rafal Lunio, Director of Research & Development; Qualified Person (QP), Polfa Tarchomin S.A
Can Expanding Data Sources in Pharma lead to Faster Drug Development?
James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences
Key Considerations When Selecting an Ideal MDI Manufacturing Partner
Craig Sommerville, Senior Vice President, Metered-Dose Inhaler Business Unit, Kindeva
Electronic Prescription Service (EPS) and Controlled Drug (CD) Prescribing
Leyla Hannbeck, Chief Pharmacist and Director of Pharmacy, National Pharmacy Association
The European Medical Devices Regulation in the Scope of Labelling and Artwork
Karolina Komposh, Labelling & Artwork, Croma-Pharma
